Mucocutaneous Lymph Node Syndrome: all 64 studies

Page 1 of 1. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki DiseaseNot yet recruitingNCT07686770Phase 2/3
• Statins Study in Children of Acute Kawasaki Disease With Coronary Artery AbnormalitiesRecruitingNCT07530640Phase 3
• MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS)Not yet recruitingNCT07491926
• Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki DiseaseNot yet recruitingNCT07405658
• Kawasaki MATCH TrialRecruitingNCT07291245Not applicable
• Cardiovascular Risk in Children With Chronic Conditions StudyRecruitingNCT07086989
• Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 YearsRecruitingNCT06993636
• Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki DiseaseRecruitingNCT06978439Phase 4
• Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)RecruitingNCT06775457Not applicable
• Non Inferiority KawasakI Trial With AnakinraNot yet recruitingNCT06697431Phase 4
• Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular DiseaseEnrolling by invitationNCT06641843
• The Value of Cardiovascular Imaging in Kawasaki DiseaseEnrolling by invitationNCT06641817
• European and North Indian Cohort of KaWasaki dIseaseRecruitingNCT06305611
• Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart DiseasesNot yet recruitingNCT05911386
• Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki DiseaseRecruitingNCT05643651Phase 4
• A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG TreatmentRecruitingNCT04656184Phase 3
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)RecruitingNCT04278404
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
• Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki DiseaseCompletedNCT04747847Early Phase 1Results posted
• KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)CompletedNCT03065244Phase 3Results posted
• Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki DiseaseCompletedNCT02179853Phase 1/2Results posted
• Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki DiseaseActive, not recruitingNCT01917721Phase 2Results posted
• Clinical Study of TA-650 in Patients With Refractory Kawasaki DiseaseCompletedNCT01596335Phase 3Results posted
• Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery AbnormalitiesCompletedNCT01431105Phase 1/2Results posted
• A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki DiseaseCompletedNCT00841789Phase 2Results posted
• Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki DiseaseCompletedNCT00760435Phase 3Results posted
• Infliximab (Remicade) for Patients With Acute Kawasaki DiseaseCompletedNCT00271570Phase 1Results posted
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki DiseaseCompletedNCT00162032Phase 3Results posted
• Kawasaki Disease During the COVID-19 EpidemicCompletedNCT06309303
• Role of Calcium Binding Protein S100A12 in Diagnosis and Prognosis of Kawasaki DiseaseStatus unknownNCT05434611
• Clinical Precise Diagnosis and Treatment in the Kawasaki DiseaseStatus unknownNCT05347901
• A Blood Test to Diagnose Kawasaki DiseaseStatus unknownNCT05091229
• Defibrotide in Children With High Risk Kawasaki DiseaseActive, not recruitingNCT04777422Phase 2
• Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki DiseaseCompletedNCT04538495
• Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki DiseaseWithdrawnNCT04535518Phase 3
• Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki DiseaseStatus unknownNCT04509219Phase 1
• Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki DiseaseCompletedNCT04078568Phase 3
• Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki DiseaseCompletedNCT04003844Phase 4
• Statins Study in Kawasaki Disease Children With Coronary Artery AbnormalitiesCompletedNCT03915795
• Acute Abdomen in Kawasaki DiseaseCompletedNCT03902262
• Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017CompletedNCT03880929
• Genetic Determinants of Kawasaki DiseaseStatus unknownNCT03861130
• Cardiovascular Status of Children 5 Years After Kawasaki DiseaseCompletedNCT03750123
• A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)Status unknownNCT03200561Phase 3
• Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki DiseaseWithdrawnNCT02980263Phase 2
• A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki DiseaseStatus unknownNCT02951234Not applicable
• Measurement of Antibodies in Adults With a History of Kawasaki DiseaseStatus unknownNCT02853266
• Safety and Vascular Remodelling After BVS Implantation for Stenotic or Occluded Lesions in Children and Young Adults With KD.Status unknownNCT02771288Not applicable
• Different Doses of IVIG for Kawasaki DiseaseCompletedNCT02439996Phase 3
• Anakinra and Kawasaki DiseaseCompletedNCT02390596Phase 2
• Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki DiseaseStatus unknownNCT02359643Not applicable
• Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012CompletedNCT02317913
• Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised TrialCompletedNCT02298062Phase 3
• Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
• Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki DiseaseStatus unknownNCT02114099Phase 2
• Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki DiseaseCompletedNCT01524939Phase 4
• Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki DiseaseCompletedNCT01440075Not applicable
• Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance ImagingCompletedNCT00861848
• Cardiovascular Risk Markers and Response to Statins After Kawasaki DiseaseWithdrawnNCT00305201Phase 2
• A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric SubjectsCompletedNCT00162045Phase 1/2
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersCompletedNCT00157079Phase 3
• Etiology Study of Kawasaki DiseaseStatus unknownNCT00154596
• Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart NetworkCompletedNCT00132080Phase 3
• Prevention of Coronary Aneurysms in Kawasaki SyndromeCompletedNCT00000520Phase 2

← Mucocutaneous Lymph Node Syndrome overview